DECREASED OXIDATIVE DEAMINATION OF CATECHOLAMINES ASSOCIATED WITH CLINICAL SCLERODERMA.
D035843:Biomedical Research; D002395:Catecholamines; D003641:Deamination; D004837:Epinephrine; D006801:Humans; D008333:Mandelic Acids; D008996:Monoamine Oxidase Inhibitors; D009638:Norepinephrine; D009647:Normetanephrine; D010084:Oxidation-Reduction; D012595:Scleroderma, Systemic; D014556:Urine
D002395:Catecholamines; D008333:Mandelic Acids; D008996:Monoamine Oxidase Inhibitors; D009647:Normetanephrine; C037938:mandelic acid; D009638:Norepinephrine; D004837:Epinephrine
CATECHOLAMINES; CLINICAL RESEARCH; EPINEPHRINE; MANDELIC ACID; MONOAMINE OXIDASE INHIBITORS; NOREPINEPHRINE; NORMETANEPHRINE; SCLERODERMA; URINE